The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Guardant Health Inc (NASDAQ: GH) was $27.57 for the day, down -4.10% from the previous closing price of $28.75. In other words, the price has decreased by -$4.10 from its previous closing price. On the day, 1.22 million shares were traded. GH stock price reached its highest trading level at $28.7199 during the session, while it also had its lowest trading level at $27.48.
Ratios:
Our analysis of GH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.66 and its Current Ratio is at 5.95. In the meantime, Its Debt-to-Equity ratio is 19.73 whereas as Long-Term Debt/Eq ratio is at 19.33.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 04 ’24 when Joyce Meghan V. sold 100 shares for $27.87 per share. The transaction valued at 2,787 led to the insider holds 4,621 shares of the business.
Kalia Kumud bought 2,187 shares of GH for $38,963 on Mar 18 ’24. The Chief Information Officer now owns 12,722 shares after completing the transaction at $17.82 per share. On Mar 04 ’24, another insider, Joyce Meghan V., who serves as the Director of the company, sold 100 shares for $19.05 each. As a result, the insider received 1,905 and left with 4,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 3373713408 and an Enterprise Value of 3692167168. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.59 while its Price-to-Book (P/B) ratio in mrq is 49.17. Its current Enterprise Value per Revenue stands at 6.116 whereas that against EBITDA is -9.194.
Stock Price History:
The Beta on a monthly basis for GH is 1.13, which has changed by -0.2767576 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $41.06, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 8.75%, while the 200-Day Moving Average is calculated to be 15.04%.
Shares Statistics:
GH traded an average of 2.14M shares per day over the past three months and 1236620 shares per day over the past ten days. A total of 121.63M shares are outstanding, with a floating share count of 115.97M. Insiders hold about 5.23% of the company’s shares, while institutions hold 93.57% stake in the company. Shares short for GH as of 1718323200 were 7626192 with a Short Ratio of 3.57, compared to 1715731200 on 10759821. Therefore, it implies a Short% of Shares Outstanding of 7626192 and a Short% of Float of 6.5.
